Sanofi Selling Medley Unit To Brazilian Drug Co. For $500M
French drugmaker Sanofi will sell 100% of Medley, one of Brazil's leading generic drug brands, to Brazilian pharmaceutical conglomerate Grupo EMS, the companies announced Friday. ...To view the full article, register now.
Already a subscriber? Click here to view full article